FDA approves Janssen's Carvykti for multiple myeloma.(RX Retail Pharmacy: BRANDED DRUGS)

Press/Media

Period	14 Mar 2022

Media coverage

Title FDA approves Janssen's Carvykti for multiple myeloma.(RX Retail Pharmacy: BRANDED DRUGS)
Media name/outlet Chain Drug Review
Country/Territory United States
Date 14/03/22
Persons Sundar Jagannath

Title	FDA approves Janssen's Carvykti for multiple myeloma.(RX Retail Pharmacy: BRANDED DRUGS)
Media name/outlet	Chain Drug Review
Country/Territory	United States
Date	14/03/22
Persons	Sundar Jagannath